Yang Feng
7PUBLICATIONS
58CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 20, 2025
DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency.Thomas Köhnke, Daiki Karigane, Eleanor Hilgart
|Jan 23, 2024
IDH1-Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation.Niklas Landberg, Thomas Köhnke, Yang Feng
|Dec 13, 2023
IDH1-mutant preleukemic hematopoietic stem cells can be eliminated by inhibition of oxidative phosphorylation.Niklas Landberg, Thomas Köhnke, Yang Feng
|Aug 24, 2023
Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer.Yang Feng, Qingchen Yuan, Rachel C Newsome
|Aug 09, 2022
miR-196b-TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML.Holly A Gamlen, Jennifer S Romer-Seibert, Michael E Lawler
|Oct 30, 2021
DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication Forks.Kartika Venugopal, Yang Feng, Pawel Nowialis
Pageof 2
Frequent Collaborators
3 joint publications
Kartika Venugopal
3 joint publications
Yusuke Nakauchi
3 joint publications
Ravindra Majeti
3 joint publications
Daiki Karigane
3 joint publications
Thomas Köhnke
3 joint publications
Amy C Fan
2 joint publications
Kelly Lim
2 joint publications
Alberto Riva
2 joint publications
Miles H Linde
2 joint publications
Olga A Guryanova
